Update of Serratia marcescens Bacteremia Associated with Contaminated Magnesium Sulfate
In follow-up to the previous notification of S. marcescens bacteremia associated with contaminated magnesium sulfate from PharMEDium (March 18, 2005), the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration have obtained new information in their ongoing investigation.
Because evidence exists to implicate at least three contaminated PharMEDium lots of magnesium sulfate, CDC recommends that magnesium sulfate solution from Pharmedium not be administered to patients until the scope of contamination can be determined. PharMEDium is voluntarily recalling all 50 ml. magnesium sulfate admixtures.
These 50 ml preparations will not be available until further notice.
See more information designed specifically for health care providers.